Oaktree Specialty Lending (OCSL) Cash & Equivalents (2021 - 2026)

Oaktree Specialty Lending has reported Cash & Equivalents for 6 years, with the latest figure at $51.3 million in Q1 2026.

• Quarterly Cash & Equivalents fell 47.61% year-over-year to $51.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $51.3 million (down 47.61% YoY) and the FY2025 annual result came in at $79.6 million, up 24.49% from the prior year.
• Cash & Equivalents retreated to $51.3 million in Q1 2026 per OCSL's latest filing, from $80.8 million in the prior quarter.
• Over five years, Cash & Equivalents peaked at $136.4 million in Q3 2023 and troughed at $17.4 million in Q4 2022.
• A 5-year average of $78.7 million and a median of $79.8 million in 2025 frame the typical range for Cash & Equivalents.
• The sharpest annual moves came in 2023 and 2024: Cash & Equivalents surged 546.47% in 2023, then plunged 53.12% in 2024.
• Over 5 years, Cash & Equivalents stood at $17.4 million in 2022, then soared by 546.47% to $112.4 million in 2023, then advanced by 0.48% to $112.9 million in 2024, then declined by 28.43% to $80.8 million in 2025, then plunged by 36.57% to $51.3 million in 2026.
• According to Business Quant data, Cash & Equivalents over the past three periods registered $51.3 million, $80.8 million, and $79.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.